Abstract
Statistical analysis plan for the BCG-DENMARK-ELDERLY-study part A and B:
Part A: Using BCG vaccine to enhance non-specific protection of senior citizens during the COVID-19 pandemic. A randomized clinical trial (BCG-DENMARK-SENIOR).
Part B: Using BCG vaccine to strengthen the immune system in the elderly and improve the response to influenza vaccine. A randomized clinical trial (BCG-DENMARK-INFLUENZA).
Part A: Using BCG vaccine to enhance non-specific protection of senior citizens during the COVID-19 pandemic. A randomized clinical trial (BCG-DENMARK-SENIOR).
Part B: Using BCG vaccine to strengthen the immune system in the elderly and improve the response to influenza vaccine. A randomized clinical trial (BCG-DENMARK-INFLUENZA).
Original language | English |
---|---|
Publication date | 19. May 2023 |
Number of pages | 42 |
Publication status | Published - 19. May 2023 |
Keywords
- BCG
- Non-specific vaccine effects
- Trained immunity
- Senior Citizen
- SAP